POMS Corporation offers a World Class Manufacturing Execution System (MES) in web and cloud-based platforms for the Pharma, Biotech, Cell & Gene Therapy industries. Founded in 1987 and headquartered in the United States, the company is dedicated to enhancing the efficiency, competitiveness, and compliance of regulated manufacturers through its proven MES solutions.
The company's commitment to delivering seamless integration with other enterprise applications and unparalleled industry knowledge and validation experience in the cGMP environment distinguishes POMS Corporation within the space. Its MES and Business Intelligence Products have set the standard for manufacturing in regulated industries, including Pharmaceutical, Biotechnology, Medical Device, and Consumer Packaged Goods.
As of the latest available information, there is no public data regarding the last investment or the related investors for POMS Corporation.